Anders Sönnerborg

17.8k total citations
324 papers, 9.2k citations indexed

About

Anders Sönnerborg is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Anders Sönnerborg has authored 324 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 255 papers in Virology, 212 papers in Infectious Diseases and 79 papers in Epidemiology. Recurrent topics in Anders Sönnerborg's work include HIV Research and Treatment (255 papers), HIV/AIDS drug development and treatment (156 papers) and HIV/AIDS Research and Interventions (149 papers). Anders Sönnerborg is often cited by papers focused on HIV Research and Treatment (255 papers), HIV/AIDS drug development and treatment (156 papers) and HIV/AIDS Research and Interventions (149 papers). Anders Sönnerborg collaborates with scholars based in Sweden, United States and Italy. Anders Sönnerborg's co-authors include Ujjwal Neogi, Piotr Nowak, Hans Gaines, Ola Weiland, Jan Andersson, Francesca Chiodi, Jan Albert, Matti Sällberg, Magnus Gisslén and Annika C. Karlsson and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Anders Sönnerborg

319 papers receiving 8.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Anders Sönnerborg 5.3k 4.5k 2.5k 2.4k 1.1k 324 9.2k
Michael A. Polis 4.3k 0.8× 3.5k 0.8× 2.9k 1.1× 2.8k 1.2× 656 0.6× 143 8.6k
Shinichi Oka 3.2k 0.6× 4.3k 0.9× 2.8k 1.1× 1.4k 0.6× 1.0k 0.9× 475 8.1k
Gregory K. Robbins 4.3k 0.8× 4.2k 0.9× 3.0k 1.2× 2.5k 1.1× 787 0.7× 143 9.9k
Richard T. Davey 6.3k 1.2× 6.2k 1.4× 3.2k 1.3× 3.5k 1.5× 1.2k 1.1× 170 11.8k
Charles Flexner 5.3k 1.0× 5.7k 1.3× 2.4k 0.9× 1.9k 0.8× 1.5k 1.4× 181 10.8k
Joseph B. Margolick 5.4k 1.0× 4.2k 0.9× 2.3k 0.9× 2.8k 1.2× 1.1k 1.0× 134 9.1k
Carlo Federico Perno 6.9k 1.3× 8.0k 1.8× 3.5k 1.4× 1.3k 0.5× 2.5k 2.2× 558 13.4k
Eric S. Daar 7.2k 1.4× 7.3k 1.6× 2.9k 1.1× 1.6k 0.7× 815 0.7× 239 11.5k
Cécile Goujard 5.0k 0.9× 4.0k 0.9× 2.0k 0.8× 2.8k 1.2× 649 0.6× 230 8.2k
Luc Perrin 4.8k 0.9× 4.1k 0.9× 2.4k 1.0× 2.6k 1.1× 1.1k 1.0× 160 9.1k

Countries citing papers authored by Anders Sönnerborg

Since Specialization
Citations

This map shows the geographic impact of Anders Sönnerborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Sönnerborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Sönnerborg more than expected).

Fields of papers citing papers by Anders Sönnerborg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Sönnerborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Sönnerborg. The network helps show where Anders Sönnerborg may publish in the future.

Co-authorship network of co-authors of Anders Sönnerborg

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Sönnerborg. A scholar is included among the top collaborators of Anders Sönnerborg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Sönnerborg. Anders Sönnerborg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lundgren, Erik, Ethan Romero-Severson, Mirjana Dimitrijević, et al.. (2024). Sweden surpasses the UNAIDS 95-95-95 target: estimating HIV-1 incidence, 2003 to 2022. Eurosurveillance. 29(42). 4 indexed citations
2.
García, Féderico, Anders Sönnerborg, Michael Böhm, et al.. (2023). Generating synthetic clinical data that capture class imbalanced distributions with generative adversarial networks: Example using antiretroviral therapy for HIV. Journal of Biomedical Informatics. 144. 104436–104436. 20 indexed citations
3.
Björkman, Per, Maurizio Zazzi, Michael Böhm, et al.. (2023). Low‐level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression. HIV Medicine. 25(1). 107–116. 4 indexed citations
4.
Rossetti, Barbara, Francesca Incardona, Francesco Saladini, et al.. (2023). Cohort Profile: A European Multidisciplinary Network for the Fight against HIV Drug Resistance (EuResist Network). Tropical Medicine and Infectious Disease. 8(5). 243–243. 7 indexed citations
5.
Ceña‐Diez, Rafael, Shilpa Ray, Jimmy Rodriguez Murillo, et al.. (2023). Naturally occurring dipeptide from elite controllers with dual anti-HIV-1 mechanism. International Journal of Antimicrobial Agents. 61(5). 106792–106792. 3 indexed citations
6.
Elvstam, Olof, Gaetano Marrone, Felipe García, et al.. (2022). Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort. Clinical Infectious Diseases. 76(1). 25–31. 46 indexed citations
7.
Spratt, Austin N., Saathvik R. Kannan, Kalicharan Sharma, et al.. (2022). Continued Complexity of Mutations in Omicron Sublineages. Biomedicines. 10(10). 2593–2593. 3 indexed citations
8.
Kannan, Saathvik R., Austin N. Spratt, Kalicharan Sharma, et al.. (2022). Complex Mutation Pattern of Omicron BA.2: Evading Antibodies without Losing Receptor Interactions. International Journal of Molecular Sciences. 23(10). 5534–5534. 12 indexed citations
9.
Ceña‐Diez, Rafael, Kamalendra Singh, Anna‐Lena Spetz, & Anders Sönnerborg. (2022). Novel Naturally Occurring Dipeptides and Single-Stranded Oligonucleotide Act as Entry Inhibitors and Exhibit a Strong Synergistic Anti-HIV-1 Profile. Infectious Diseases and Therapy. 11(3). 1103–1116. 6 indexed citations
10.
Rossetti, Barbara, Massimiliano Fabbiani, Domenico Di Carlo, et al.. (2022). Effectiveness of integrase strand transfer inhibitors in HIV‐infected treatment‐experienced individuals across Europe. HIV Medicine. 23(7). 774–789. 4 indexed citations
11.
Bai, Xiangning, et al.. (2022). Characterization of the Upper Respiratory Bacterial Microbiome in Critically Ill COVID-19 Patients. Biomedicines. 10(5). 982–982. 9 indexed citations
12.
Kretschmer, Martin, Rafael Ceña‐Diez, Illia Dobryden, et al.. (2022). Synthetic Mucin Gels with Self‐Healing Properties Augment Lubricity and Inhibit HIV‐1 and HSV‐2 Transmission. Advanced Science. 9(32). e2203898–e2203898. 12 indexed citations
13.
Spratt, Austin N., Saathvik R. Kannan, Lucas T. Woods, et al.. (2021). Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants. Computational and Structural Biotechnology Journal. 19. 3799–3809. 21 indexed citations
14.
Rossetti, Barbara, Massimiliano Fabbiani, Domenico Di Carlo, et al.. (2021). Effectiveness of integrase strand transfer inhibitor-based regimens in HIV-infected treatment-naive individuals: results from a European multi-cohort study. Journal of Antimicrobial Chemotherapy. 76(9). 2394–2399. 6 indexed citations
15.
Borghetti, Alberto, Arturo Ciccullo, Francesca Lombardi, et al.. (2020). Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors. HIV Medicine. 22(1). 22–27. 6 indexed citations
16.
Zhang, Wei, et al.. (2019). Microfluidic centrifugation assisted precipitation based DNA quantification. Lab on a Chip. 19(9). 1657–1664. 13 indexed citations
17.
Vesterbacka, Jan, Javier Sandoval, Kajsa Noyan, et al.. (2017). Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers. Scientific Reports. 7(1). 6269–6269. 68 indexed citations
18.
Leeansyah, Edwin, Máire F. Quigley, Anders Sönnerborg, et al.. (2012). Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood. 121(7). 1124–1135. 283 indexed citations
19.
Vandamme, Anne–Mieke, Ricardo Camacho, Francesca Ceccherini‐Silberstein, et al.. (2011). European recommendations for the clinical use of HIV drug resistance testing: 2011 update.. PubMed. 13(2). 77–108. 104 indexed citations
20.
Prosperi, Mattia, Michal Rosen‐Zvi, André Altmann, et al.. (2011). Correction: Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models. PLoS ONE. 6(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael A. Polis Breakdown of academic impact, for papers by Shinichi Oka Breakdown of academic impact, for papers by Gregory K. Robbins Breakdown of academic impact, for papers by Richard T. Davey Breakdown of academic impact, for papers by Charles Flexner Breakdown of academic impact, for papers by Joseph B. Margolick Breakdown of academic impact, for papers by Carlo Federico Perno Breakdown of academic impact, for papers by Eric S. Daar Breakdown of academic impact, for papers by Cécile Goujard Breakdown of academic impact, for papers by Luc Perrin
Rankless by CCL
2026